Avaí Bio, Inc. (AVAI)
OTCMKTS
· Delayed Price · Currency is USD
0.360
-0.020 (-5.26%)
Mar 5, 2026, 3:30 PM EST
Avaí Bio Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2018 |
| Revenue | - | - | - | 0.28 | 0.92 | 1.21 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -70.01% | -24.12% | 69.23% | Upgrade
|
| Cost of Revenue | - | - | - | 0.32 | 0.71 | 1.23 | Upgrade
|
| Gross Profit | - | - | - | -0.04 | 0.21 | -0.02 | Upgrade
|
| Selling, General & Admin | 1.29 | 1.46 | 2.04 | 0.3 | 0.51 | 0.23 | Upgrade
|
| Research & Development | 0.02 | - | - | - | - | - | Upgrade
|
| Other Operating Expenses | -0.32 | -0.39 | 0.01 | -0.01 | -0.22 | -0 | Upgrade
|
| Operating Expenses | 1.03 | 1.14 | 2.13 | 0.31 | 0.34 | 0.29 | Upgrade
|
| Operating Income | -1.03 | -1.14 | -2.13 | -0.35 | -0.13 | -0.3 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 0 | - | - | Upgrade
|
| Pretax Income | -1.03 | -1.14 | -2.13 | -0.35 | -0.13 | -0.3 | Upgrade
|
| Net Income | -1.03 | -1.14 | -2.13 | -0.35 | -0.13 | -0.3 | Upgrade
|
| Net Income to Common | -1.03 | -1.14 | -2.13 | -0.35 | -0.13 | -0.3 | Upgrade
|
| Shares Outstanding (Basic) | 138 | 128 | 87 | 39 | 26 | 26 | Upgrade
|
| Shares Outstanding (Diluted) | 138 | 128 | 87 | 39 | 26 | 26 | Upgrade
|
| Shares Change (YoY) | 5.72% | 48.09% | 124.74% | 46.31% | 0.13% | 29.15% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.02 | -0.01 | -0.00 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.02 | -0.01 | -0.00 | -0.01 | Upgrade
|
| Free Cash Flow | -1.15 | -1.16 | -1.32 | -0.05 | -0.54 | -0.02 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.00 | -0.02 | -0.00 | Upgrade
|
| Gross Margin | - | - | - | -14.64% | 22.88% | -1.36% | Upgrade
|
| Operating Margin | - | - | - | -126.28% | -13.73% | -24.90% | Upgrade
|
| Profit Margin | - | - | - | -126.28% | -13.73% | -24.90% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -19.71% | -58.07% | -1.90% | Upgrade
|
| EBITDA | -0.99 | -1.07 | -2.05 | -0.33 | -0.09 | -0.25 | Upgrade
|
| EBITDA Margin | - | - | - | -117.80% | -9.77% | -20.46% | Upgrade
|
| D&A For EBITDA | 0.04 | 0.07 | 0.08 | 0.02 | 0.04 | 0.05 | Upgrade
|
| EBIT | -1.03 | -1.14 | -2.13 | -0.35 | -0.13 | -0.3 | Upgrade
|
| EBIT Margin | - | - | - | -126.28% | -13.73% | -24.90% | Upgrade
|
| Revenue as Reported | - | - | - | 0.28 | 0.92 | 1.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.